Viscosupplementation Market 2022 | Present Scenario and Growth Prospects 2030: MRFR
Viscosupplementation Market Overview
Viscosupplementation is a medical procedure used
to alleviate pain and restore joint functions by replenishing depleted
hyaluronic acid (HA) in the affected area. This procedure provides patients a
natural, minimally invasive, FDA approved option to treat symptoms of knee
osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, ankle, and spine
arthritis. Over recent years, the global viscosupplementation market is growing
continually, mainly due to the rising prevalence of knee osteoarthritis.
Moreover, the increasing popularity of minimally
invasive procedures and the growing geriatric population facilitate market
growth. According to Market Research Future (MRFR), the global Viscosupplementation Market valuation is
projected to reach USD 4,760
Million by 2030, at 11.32% CAGR during the review period (2022 to 2030). The
market is witnessing increasing investments in the R&D activities, which
favors the growth of the market.
Besides, factors such as growing population and
urbanization worldwide are fostering market growth. Growth in the global
economy provides a huge impetus to market growth, enabling access to improved
healthcare. Additionally, seminal efforts and investments made in the
development of Viscosupplementation products such as HA injection and etc. pay
off well, driving the market growth. Also, Government initiatives play a major
role in fostering market growth. On the other hand, stringent government
regulations and a rise in insurance denials for viscosupplementation products
act as major headwind restricting the market growth. Also, factors such as low
awareness among people about the availability of treatment and high
manufacturing cost of viscosupplementation products are likely to impede the
market growth. Nevertheless, the rising demand for effective non-invasive
treatments for knee pain would support market growth throughout the forecast
period.
Market Segmentation
The report is segmented into five main dynamics
to widen the scope of understanding,
By Hyaluronic Acid Type : Stabilized
Hyaluronic Acid and Standard Hyaluronic Acid.
By Procedure
Type : Single-Injection
Procedure, Three-Injection Procedure, and Five-Injection Procedure.
By
Application :
Knee Arthritis and Hip Osteoarthritis.
By
End-user :
Hospitals & Clinics, Ambulatory Surgical Centers, and others.
By
Regions :
Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World
Regional
Analysis
North America dominates the global
viscosupplementation market. The largest share of the market attributes to the
rising preferences for minimally invasive viscosupplementation procedures in
the treatment of knee osteoarthritis, instead of knee replacement surgeries.
Besides, the presence of viscosupplementation providers and doctors alongside,
the sophisticated healthcare infrastructure impacts the market growth
positively. There has been a sudden increase in the demand for
viscosupplementation products in the US due to which the US
viscosupplementation market is estimated to grow double-fold.
With the continually rising incidents of
knee arthritis, the European viscosupplementation market is expected to
continue with its second-leading position. Besides, favorable government
regulations help in the proliferation of the market in the region. Moreover,
the increased research & development activities in the field backed by
government support and funds.
The Asia Pacific region is an emerging market for
viscosupplementation. Growing markets in India and China, backed by the growing
prevalence of knee and hip osteoarthritis, provide impetus to the market
growth. Additionally, increasing awareness among patients about the
availability of the non-invasive HA-enhanced bone repair therapy drives a large
share of the regional market. Furthermore, the huge patient population
suffering from the knee & joints pain alongside the burgeoning medical
treatment market in the region influences the regional market growth.
KeyPlayers
Viscosupplementation Market Players are,
Allergan, Sanofi, Hoffmann-La Roche, Smith & Nephew
Plc, Zimmer Biome, Anika Therapeutics Inc.,Ferring
B.V., Bioventus,Fidia Farmaceutici S.P.A.
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research
and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment